Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
ScheBo® Biotech AG
Netanyastrasse 3
35394 Giessen, Germany


Phone +49 -(0)641 -4996-0
Fax +49 -(0)641 -4996-77
Email-contact

ScheBo® Tumor M2-PK™ ELISA Stool Test

The metabolic biomarker "Faecal Tumor M2-PK" is a screening parameter for colorectal (bowel) cancer and polyps and is independent of "Faecal Occult Blood" (FOB).


The ScheBo® Tumor M2-PK™ Stool Test is a totally new approach, which is much more sensitive than previous laboratory bowel cancer secreening tests. Previosly, only non-specific tests for blood in the stool could be used to give an indication of an existing bowel cancer or its precursors. With the new ELISA method for Tumor M2-PK in the stool it′s now possible to detect bleeding or non-bleeding bowel cancers, as well as polyps, with high sensitivty and specificity. The test is much more accurate because it is not dependent on occult blood.




A Decade of UK Success for Schebo Biotech
ScheBo® Biotech UK Limited, a leading provider of unique in-vitro diagnostic tests for the healthcare sector, has just celebrated its 10th Anniversary.
more...
A superior alternative for PLT users: Faecal Pancreatic Elastase Test
Pfizer recommends this test in a letter it sent to pharmacists notifying them about the withdrawal of PLT.
more...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
more...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
more...
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
Fecal tumor M2-PK is an appropriately sensitve tool to pre-select those patients requiring colonoscopy for the further diagnostic confirmation or exclusion of colorectal cancer.
more...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
more...